Case study: impact of pathogen inactivation on outdating rates and supply continuity

Back to all videos

About the expert

Landro (2)

Ms. Ragna Landrö, BSc
The Blood Bank, The National University Hospital of Iceland, Reykjavík
Reykjavík, Iceland

Background information

B.Sc. in molecular biology, University of Iceland
Manager of Blood Production, 2020

Topic of the talk

Impact of PI on outdating rates and supply continuity.

Legal Info
Privacy Policy
Cookies

The information on this site is not country-specific, and may contain information that is outside the approved indications for the country in which you are located.
Use of INTERCEPT Plasma or Platelets is contraindicated in patients with a history or allergic response to amotosalen or psoralens. Consult instructions for use for indications, contraindications, warnings, and precautions.

Cerus, INTERCEPT and the Cerus logo are trademarks of Cerus Corporation.